Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Novavax Fell by Over 4% Today

TheMotleyFool

0 0

Novavax (NASDAQ: NVAX) stumbled on Monday, with the stock declining by 4.4%. The key reason for the coronavirus vaccine developer's decline seems to be a set of company stock sales reported for top insiders earlier in the day.

Citing regulatory filings, Reuters reported that the biotech's CEO, Stanley Erck, and "three lieutenants" it did not name have sold around $46 million worth of Novavax stock since the beginning of 2020.

Image source: Getty Images.

Source Fool.com

Like: 0

NVAX

Teilen